SCHEMBL20740893

SCHEMBL20740893

N#Cc1c(F)c(-c2ccncc2)c(-c2ccncc2)c(-c2ccncc2)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
HPGD P15428 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
MAPK1 P28482 1/20 0.42
MET P08581 2/20 0.41
ADORA1 P30542 2/20 0.41
ADORA2A P29274 1/20 0.41
MAPT P10636 3/20 0.41
PKM P14618 1/20 0.41
CUL4A Q13619 1/20 0.41
APOBEC3G Q9HC16 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SQOR Q9Y6N5 1/20 0.40
LMNA P02545 1/20 0.39
MAPK14 Q16539 2/20 0.38
CSNK1A1 P48729 1/20 0.38
CSNK1D P48730 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21677421 0.88 KDM4E (0.42) KDM4EALDH1A1HSD17B10HPGDMEN1
SCHEMBL12681345 0.81 MAPT (0.48) KDM4EALDH1A1HSD17B10HPGDMEN1
SCHEMBL12679796 0.76 ADORA1 (0.57) KDM4EALDH1A1HSD17B10HPGDMEN1
SCHEMBL4378709 0.75 MAPT (0.53) KDM4EMAPTPKMLMNAMAPK14
SCHEMBL21578111 0.73 MAPT (0.56) KDM4EMAPTPKMLMNAMAPK14
SCHEMBL4302102 0.72 MAPT (0.71) KDM4EALDH1A1MEN1KMT2AMAPK1
SCHEMBL25992020 0.72 ADORA1 (0.57) KDM4EALDH1A1HSD17B10HPGDMEN1
SCHEMBL19909038 0.72 TRPV4 (0.47) ADORA1ADORA2AMAPTSQORLMNA
SCHEMBL19908987 0.72 SQOR (0.43) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL24701506 0.71 HSD17B10 (0.47) KDM4EALDH1A1HSD17B10HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11069860-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2021-07-20 US disclosed
US-11069860-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2021-07-20 US disclosed
US-20190058130-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-02-21 US disclosed
US-20190058130-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11069860-B2 Composition of matter for use in organic light-emitting diodes ALDH1A2, CYBA, CRY2 KDM4E 4245/4885ALDH1A1 56/4885HSD17B10 2949/4885
US-20190058130-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES ALDH1A2, CYBA, CRY2 KDM4E 4245/4885ALDH1A1 56/4885HSD17B10 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.